203 related articles for article (PubMed ID: 14530472)
1. Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET.
Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
J Nucl Med; 2003 Oct; 44(10):1592-8. PubMed ID: 14530472
[TBL] [Abstract][Full Text] [Related]
2. Measurement of skeletal muscle glucose utilization by dynamic 18F-FDG PET without arterial blood sampling.
Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
Nucl Med Commun; 2005 Jan; 26(1):31-7. PubMed ID: 15604945
[TBL] [Abstract][Full Text] [Related]
3. Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT.
Gheysens O; Postnov A; Deroose CM; Vandermeulen C; de Hoon J; Declercq R; Dennie J; Mixson L; De Lepeleire I; Van Laere K; Klimas M; Chakravarthy MV
J Nucl Med; 2015 Oct; 56(10):1520-6. PubMed ID: 26229142
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.
Yokoyama I; Yonekura K; Moritan T; Tateno M; Momose T; Ohtomo K; Inoue Y; Nagai R
J Nucl Med; 2001 Jul; 42(7):1005-10. PubMed ID: 11438619
[TBL] [Abstract][Full Text] [Related]
5. Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18F-FDG, the ATLAS small animal PET scanner, and arterial blood sampling.
Shimoji K; Ravasi L; Schmidt K; Soto-Montenegro ML; Esaki T; Seidel J; Jagoda E; Sokoloff L; Green MV; Eckelman WC
J Nucl Med; 2004 Apr; 45(4):665-72. PubMed ID: 15073264
[TBL] [Abstract][Full Text] [Related]
6. Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
Trägårdh M; Møller N; Sørensen M
J Nucl Med; 2015 Sep; 56(9):1366-71. PubMed ID: 26159590
[TBL] [Abstract][Full Text] [Related]
7. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
8. Determination of the lumped constant for [18F] fluorodeoxyglucose in human skeletal muscle.
Kelley DE; Williams KV; Price JC; Goodpaster B
J Nucl Med; 1999 Nov; 40(11):1798-804. PubMed ID: 10565773
[TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation of skeletal tumours with dynamic FDG PET: SUV in comparison to Patlak analysis.
Wu H; Dimitrakopoulou-Strauss A; Heichel TO; Lehner B; Bernd L; Ewerbeck V; Burger C; Strauss LG
Eur J Nucl Med; 2001 Jun; 28(6):704-10. PubMed ID: 11440030
[TBL] [Abstract][Full Text] [Related]
10. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
[TBL] [Abstract][Full Text] [Related]
11. SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.
Beaulieu S; Kinahan P; Tseng J; Dunnwald LK; Schubert EK; Pham P; Lewellen B; Mankoff DA
J Nucl Med; 2003 Jul; 44(7):1044-50. PubMed ID: 12843218
[TBL] [Abstract][Full Text] [Related]
12. Insulin action on heart and skeletal muscle FDG uptake in patients with hypertriglyceridemia.
Yokoyama I; Ohtake T; Momomura S; Yonekura K; Kobayakawa N; Aoyagi T; Sugiura S; Yamada N; Ohtomo K; Sasaki Y; Omata M; Yazaki Y
J Nucl Med; 1999 Jul; 40(7):1116-21. PubMed ID: 10405129
[TBL] [Abstract][Full Text] [Related]
13. Lumped constant for [(18)F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans.
Peltoniemi P; Lönnroth P; Laine H; Oikonen V; Tolvanen T; Grönroos T; Strindberg L; Knuuti J; Nuutila P
Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1122-30. PubMed ID: 11052968
[TBL] [Abstract][Full Text] [Related]
14. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.
Toyama H; Ichise M; Liow JS; Modell KJ; Vines DC; Esaki T; Cook M; Seidel J; Sokoloff L; Green MV; Innis RB
J Nucl Med; 2004 Aug; 45(8):1398-405. PubMed ID: 15299067
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 1-(11)C-glucose and (18)F-FDG for quantifying myocardial glucose use with PET.
Herrero P; Sharp TL; Dence C; Haraden BM; Gropler RJ
J Nucl Med; 2002 Nov; 43(11):1530-41. PubMed ID: 12411556
[TBL] [Abstract][Full Text] [Related]
16. Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics.
Strauss LG; Dimitrakopoulou-Strauss A; Haberkorn U
J Nucl Med; 2003 Dec; 44(12):1933-9. PubMed ID: 14660719
[TBL] [Abstract][Full Text] [Related]
17. Human adipose tissue glucose uptake determined using [(18)F]-fluoro-deoxy-glucose ([(18)F]FDG) and PET in combination with microdialysis.
Virtanen KA; Peltoniemi P; Marjamäki P; Asola M; Strindberg L; Parkkola R; Huupponen R; Knuuti J; Lönnroth P; Nuutila P
Diabetologia; 2001 Dec; 44(12):2171-9. PubMed ID: 11793018
[TBL] [Abstract][Full Text] [Related]
18. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues.
Paquet N; Albert A; Foidart J; Hustinx R
J Nucl Med; 2004 May; 45(5):784-8. PubMed ID: 15136627
[TBL] [Abstract][Full Text] [Related]
19. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
Cohade C; Osman M; Pannu HK; Wahl RL
J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
[TBL] [Abstract][Full Text] [Related]
20. Exercise training favors increased insulin-stimulated glucose uptake in skeletal muscle in contrast to adipose tissue: a randomized study using FDG PET imaging.
Reichkendler MH; Auerbach P; Rosenkilde M; Christensen AN; Holm S; Petersen MB; Lagerberg A; Larsson HB; Rostrup E; Mosbech TH; Sjödin A; Kjaer A; Ploug T; Hoejgaard L; Stallknecht B
Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E496-506. PubMed ID: 23800880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
